Workflow
Implant Direct DIRECTscan
icon
Search documents
Envista(NVST) - 2025 Q2 - Earnings Call Presentation
2025-07-31 21:00
Q2 2025 Performance - Core sales growth reached 5.6%[16], with adjusted EBITDA margin at 12.4%[16] and adjusted EPS at $0.26, a 136% year-on-year increase[16] - Specialty Products & Technologies (SP&T) experienced a core sales growth of 4.7%[16], while Equipment & Consumables (E&C) saw a core sales growth of 7.3%[16] - Free cash flow was $76 million[28] H1 2025 Performance - Core sales growth was 2.9%[16], with adjusted EBITDA margin at 12.6%[16] and adjusted EPS at $0.50, a 35% year-on-year increase[16] FY2025 Updated Guidance - Core sales growth guidance raised from 1-3% to 3-4%[16] - EPS guidance increased from $0.95 - $1.05 to $1.05 - $1.15[16] - Adjusted EBITDA margin guidance maintained at approximately 14%[16] Revenue and Growth Analysis - Q2 2025 revenue was $682.1 million, an increase of $49.0 million compared to $633.1 million in Q2 2024[25] - Reported revenue growth was 7.7%, with core growth contributing 5.6%[29] Adjusted EBITDA Analysis - Adjusted EBITDA for Q2 2025 was $84.3 million, compared to $63.0 million in Q2 2024, representing a 34% increase[27, 25] - Adjusted EBITDA margin increased by 240 bps to 12.4%[27, 25]